Effectiveness and Safety of Albuterol Solutions With and Without Benzalkonium Chloride

REFERENCES

1. 1.↵
   1. Peters SG

   . Continuous bronchodilator therapy. Chest 2007;131(1):286-289.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Kenyon CC,
   2. Fieldston ES,
   3. Luan X,
   4. Keren R,
   5. Zorc JJ

   . Safety and effectiveness of continuous aerosolized albuterol in the non–intensive care setting. Pediatrics 2014;134(4):e976-e982.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Lin AT,
   2. Moore-Clingenpeel M,
   3. Karsies TJ

   . Comparison of two continuous nebulized albuterol doses in critically ill children with status asthmaticus. J Asthma 2019:1-7.
4. 4.↵
   1. Nievas IF,
   2. Anand KJ

   . Severe acute asthma exacerbation in children: a stepwise approach for escalating therapy in a pediatric intensive care unit. J Pediatr Pharmacol Ther 2013;18(2):88-104.

   OpenUrlPubMed
5. 5.↵
   1. Craig VL,
   2. Bigos D,
   3. Brilli RJ

   . Efficacy and safety of continuous albuterol nebulization in children with severe status asthmaticus. Pediatr Emerg Care 1996;12(1):1-5.

   OpenUrlPubMedWeb of Science
6. 6.↵
   1. Papo MC,
   2. Frank J,
   3. Thompson AE

   . A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med 1993;21(10):1479-1486.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Prabhakaran S,
   2. Abu-Hasan M,
   3. Hendeles L

   . Benzalkonium chloride: a bronchoconstricting preservative in continuous albuterol nebulizer solutions. Pharmacotherapy 2017;37(5):607-610.

   OpenUrl
8. 8.↵
   1. Orth LE,
   2. Kelly BJ,
   3. Lagasse CA,
   4. Collins SW,
   5. Ryan MF

   . Safety and effectiveness of albuterol solutions with and without benzalkonium chloride when administered by continuous nebulization. Am J Health Syst Pharm 2018;75(22):1791-1797.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Lee BH,
   2. Kim SH

   . Benzalkonium chloride–induced bronchoconstriction in patients with stable bronchial asthma. Korean J Intern Med 2007;22(4):244-248.

   OpenUrlPubMed
10. 10.↵
    1. Asmus MJ,
    2. Barros MD,
    3. Liang J,
    4. Chesrown SE,
    5. Hendeles L

    . Pulmonary function response to EDTA, an additive in nebulized bronchodilators. J Allergy Clin Immunol 2001;107(1):68-72.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Asmus MJ,
    2. Sherman J,
    3. Hendeles L

    . Bronchoconstrictor additives in bronchodilator solutions. J Allergy Clin Immunol 1999;104(2 Pt 2):S53-60.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Pertzborn MC,
    2. Prabhakaran S,
    3. Abu-Hasan M,
    4. Baker D,
    5. Wu S,
    6. Wu Y,
    7. et al

    . Continuous albuterol with benzalkonium in children hospitalized with severe asthma. Pediatrics 2020;145(4).
13. 13.↵
    R Core Team, R Foundation for Statistical Computing. R: A language and environment for statistical computing, 2021. https://www.R-project.org.
14. 14.↵
    1. Gulley SL,
    2. Baltzley SM,
    3. Junkins AD,
    4. Murray TD,
    5. Simms SF,
    6. Sullivan JE,
    7. et al

    . Sterility and stability testing of preservative-free albuterol. J Pediatr Pharmacol Ther 2019;24(1):53-57.

    OpenUrl